|
We asked 40 leaders, Is the pharma supply chain more secure than it was five years ago?
| Gaining internal buy-in Establishing internal |
11% |
guidelines |
17% |
| Working with external guidelines |
33% |
| Recruiting staff |
22% |
| Budgeting issues |
17% |
|
|
 |
|
|
|
|
|
29 July, 2014
|
|
|
European Pharma Races to Catch Up with Data Protection Rules
As the European Union struggles to bring its data protection rules into the 21st century, the pharmaceutical sector, already out of breath from trying to catch up with data disclosure, finds itself in a new race — to avoid becoming a victim of excessive data protection.Peter O'Donnell reports Read more |
Pharm Exec’s 2014 Dealmakers Outlook
Dealmaking is today back to center stage, but with the major roles reversed— small biotech, yesterday's understudy, now gets top billing, while big Pharma has to work harder for its close-up. Pharm Exec brought partner Campbell Alliance and a select group of West Coast dealmakers to a Sonoma raceway for a test performance on what lies ahead for asset licensing and M&A activity in 2014... Read more
|
EFPIA’s Proposed “Integrated Strategy”: Be Careful What You Wish For
One of the most grandiose of the manifestos and strategy proposals from industry currently doing the rounds is EFPIA’s self-styled “groundbreaking vision towards a life sciences strategy for Europe”. But the proposals could see EFPIA jumping out of the frying pan and into the fire, writes Reflector ... Read more
|
Read the Pharm Exec Global Digest: FDA & Social Media Special
In this special issue: FDA’s Tom Abrams talks social media; What the FDA’s social media guidelines say — and what they mean; Making the most of the social media; Marketing confidence in a multichannel era.... Read more
|
|
|
|
|
